Mckesson CorpMCK

NYSEHealthcareWholesale-Drugs, Proprietaries & Druggists' Sundries
Price (close)
$869.36
Market cap
$101.4B
P/E
22.1x
Revenue (TTM)
$411.0B
Net income
$4.6B
Dividend yield
0.39%
1-year total return
18.5%
Net margin
1.1%
Revenue growth
8.8%
Debt / equity
—

What Mckesson Corp does.

McKesson Corporation together with its subsidiaries (collectively, the “Company,” “McKesson,” “we,” “our,” or “us” and other similar pronouns), which traces its business roots to 1833, is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products, and services to help make quality care more accessible and affordable.

The Company’s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references in this document to a particular year refer to the Company’s fiscal year. The Company was incorporated on July 7, 1994 in the State of Delaware.

Our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (the “Exchange Act”), are available free of charge on the Company’s website ( www.mckesson.com under the “Investors — Financials — SEC Filings” caption) as soon as reasonably practicable after such material is electronically filed with, or furnished to, the Securities and Exchange Commission (“SEC”). The content on any website referred to in this Annual Report on Form 10-K (“Annual Report”) is not incorporated by reference into this report, unless expressly noted otherwise. The SEC maintains a website that contains reports, proxy and information statements, and other information regarding issuers, including the Company, that file electronically with the SEC. The address of the website is www.sec.gov .

Revenue and profit, by fiscal year.

Fiscal year202120222023202420252026
Revenue$238.2B$264.0B$276.7B$309.0B$359.1B$403.4B
Net income-$4.5B$1.1B$3.6B$3.0B$3.3B$4.8B
Free cash flow$4.1B$4.0B$4.8B$3.9B$5.5B$5.7B

More on MCK.

Figures from Mckesson Corp's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.